Led,
I think now is a better time than any for DM to pull the trigger on that elusive license /partner deal to get the market excited.
I was also think that a pending(if you can call it that )FDA approval might give more confidence to potential institutional investors, or more credible financial analyst or even BP more confident to sign a potential partner deal. Hoping to hear some postive news soon on anything